[1] Dunnill MS, Millard PR, Oliver D. Acquired cystic disease of the kidnens: a hazard of long-term intermittent maintenance haemodialysis [J]. J Clin Pathol, 1977, 30(9):868-877. DOI: 10.1136/jcp.30.9.868.
[2] Tickoo SK, dePeralta-Venturina MN, Harik LR, et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia [J]. Am J Surg Pathol, 2006, 30(2): 141-153. DOI: 10.1097/01.pas.0000185382. 80844.b1.
[3] Moch H, Humphrey PA, Ulbright TM, et al. WHO classification of tumours of the urinary system and male genital organs [M]. Lyon: IARC Press, 2016.
[4] 饶秋,夏秋媛,周晓军,等. 2016版 WHO 肾脏肿瘤新分类解读[J]. 中华病理学杂志,2016,45(7): 435-441. DOI: 10. 3760/cma.j.issn.0529-5807.2016.07.002.
[5] 施珍,金领微,高依依,等. 血液透析患者获得性肾囊肿的临床回顾分析[J]. 中国中西医结合肾病杂志,2014,15(1):46-47.
[6] Nouh MA, Kuroda N, Yamashita M, et al. Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis [J]. BJU Int, 2010, 105(5): 620-627. DOI: 10.1111/j.1464-410X.2009.08817.x.
[7] 杨建勋,付启忠,董圣芳,等. 获得性肾囊性疾病合并肾癌11例临床分析[J]. 中华泌尿外科杂志,2011,32(2):99-102. DOI:10.3760/cma.j.issn.1000-6702.2011.02.008.
[8] Rahbari-Oskoui F, O'Neill WC. Diagnosis and management of acquired cystic kidney disease and renal tumors in ESRD patients[J]. Semin Dial, 2017, 30(4): 373-379. DOI: 10.1111/sdi.12605.
[9] 张伟,徐丽丽,于文娟,等. 获得性囊性肾病相关性肾细胞癌临床病理学观察[J]. 中华病理学杂志,2018,47(5):366-371. DOI:10.3760/cma.j.issn.0529-5807.2018.05.010.
[10] Sule N, Yakupoglu U, Shen SS, et al. Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study [J]. Am J Surg Pathol, 2005, 29(4): 443-451. DOI: 10.1097/01.pas.0000152131.58492.97.
[11] Ahn S, Kwon GY, Cho YM, et al. Acquired cystic disease-associated renal cell carcinoma: further characterization of the morphologic and immunopathologic features[J]. Med Mol Morphol, 2013, 46(4): 225-232. DOI: 10.1007/s00795-013-0028-x.
[12] Inoue T, Matsuure K, Yoshimoto T, et al. Genomic profiling of renal cell carcinoma in patients with end-stage renal disease[J]. Cancer Sci, 2012, 103(3): 569-576. DOI:10.1111/j.1349-7006.2011.02176.x.
[13] Kuroda N, Tamura M, Hamaguchi N, et al. Acquired cystic disease-associated renal cell carcinoma with sarcomatoid change and rhabdoid features[J]. Ann Diagn Pathol, 2011, 15(6): 462-466. DOI:10.1016/j.anndiagpath.2010.07.008.
[14] Bhatnagar R, Alexiev BA. Renal-cell carcinomas in end-stage kidneys: a clinicopathological study with emphasis on clear-cell papillary renal-cell carcinoma and acquired cystic kidney disease-associated carcinoma [J]. Int J Surg Pathol, 2012, 20(1): 19-28. DOI: 10.1177/1066896911414273.
[15] Przybycin CG, Harper HL, Reynolds JP, et al. Acquired cystic disease-associated renal cell carcinoma (ACD-RCC): a multiinstitutional study of 40 cases with clinical follow-up [J]. Am J Surg Pathol, 2018, 42(9): 1156-1165. DOI: 10.1097/PAS.0000000000001091.
[16] 何冰,张伟,刘莉娜,等. 终末期肾病合并肾细胞癌的临床病理学特征[J]. 中华病理学杂志,2019,48(11):846-850. DOI:10.3760/cma.j.issn.0529?5807.2019.11.003.
[17] 赵媛,陈红,金木兰. 琥珀酸脱氢酶缺陷型肾癌1例并文献复习[J]. 临床与实验病理学杂志,2019,35(12):1472-1474. DOI:10.13315/j.cnki.cjcep.2019.12.021.
[18] Kondo T, Sassa N, Yamada H, et al. Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology study[J]. Pathology, 2021, 53(6): 720-727. DOI: 10.1016/j.pathol.2021.01.014.
[19] 谢红建,宋晓霞,赵跃武,等. 获得性囊性肾病相关性肾细胞癌一例[J].中国临床案例成果数据库,2022, 4(1): E02349-E02349. DOI:10.3760/cma.j.cmcr.2022.e02349.
[20] 陈恕求, 陈明, 张晓文, 等. 长期血透患者获得性囊性肾病合并肾癌8例报告并文献复习[J]. 临床泌尿外科杂志,2012,27(1):33-35. DOI:10.13201/j.issn.1001-1420.2012. 01.014.
|